Medical/Pharmaceuticals

Illuccix® Receives European Approval

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive decision on the Marketing Authorization Application (MAA) for its prostate cancer PET[1] imaging agent ...

2025-01-17 06:14 4469

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

TAMPA, Fla., Jan. 17, 2025 /PRNewswire/ -- Concept Medical Inc. , a global pioneer in innovative drug delivery technology, is proud to announce the successful enrolment of the first patient in the "MAGICAL BTK" (Randomized Controlled Trial of MagicTouch PTA – Siro...

2025-01-17 03:15 3450

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services inHong Kong, today announced the closing o...

2025-01-17 03:10 4028

New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making

Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers PLYMOUTH MEETING, Pa., Jan. 16, 2025 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of...

2025-01-16 21:07 2458

SEACare 2025 - Your Gateway to Southeast Asia's Thriving Healthcare Market and Strategic Connections

Unlocking Opportunities in Southeast Asia's Healthcare Market KUALA LUMPUR, Malaysia, Jan. 16, 2025 /PRNewswire/ -- SEACare 2025, the Southeast Asia Healthcare & Pharma Show, returns for its 25th edition from 23 to 25 April 2025 at the Malaysian International Trade and Exhibition Centre (MIT...

2025-01-16 19:56 4084

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated2024 Year in Review ser...

2025-01-16 16:00 2298

BGI Genomics Empowers Brunei's National Cervical Cancer Prevention Program

SHENZHEN, China, Jan. 16, 2025 /PRNewswire/ -- On January 15, 2025, the Brunei Ministry of Health (MOH), in partnership with Borneo Genomics Innovation (BGIB), a joint venture of BGI Genomics inBrunei, launched the National Cervical Cancer Prevention and Control Program along with the 2025 Nation...

2025-01-16 12:51 2943

Shanghai opens its doors to foreign-owned hospitals

SHANGHAI, Jan. 14, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn Shanghai announced on Jan 8 plans to encourage the establishment of wholly foreign-owned hospitals in the municipality's key economic zones, biopharmaceutical industry clusters a...

2025-01-16 09:39 2795

(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology

TAICHUNG, Jan. 15, 2025 /PRNewswire/ -- On November 2, 2024, China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highlightTaiwan's advancements and explore new horizons in biomedical applications.Profes...

2025-01-16 09:00 2747

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2025-01-16 08:03 4286

IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis™ Infusion System

Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the introduction of theInsignis™ Infusion System into the world market. CHESTER, N.Y., Jan. 15, 202...

2025-01-15 23:05 2530

NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company inSouth Korea, proudly announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for its clinical tria...

2025-01-15 22:00 3337

BTL Unveils EXOMIND: A New Era in Mental Wellness

The breakthrough ExoTMS™ technology stimulates key brain areas, boosts neuroplasticity, and strengthens brain pathways. PRAGUE, Jan. 15, 2025 /PRNewswire/ -- BTL, the innovator in medical and aesthetic technologies, is thrilled to introduce the EXOMIND, powered by ExoTMS technology - a state-of-...

2025-01-15 20:00 4497

New Global Survey Seeks Insights on Climate and Health

— Grand Challenges Canada, Science for Africa Foundation, Global Grand Challenges Network, and Geneva Learning Foundation launch global survey to collect insights on climate and health — TORONTO, Jan. 15, 2025 /PRNewswire/ -- Grand Challenges Canada (GCC), in partnership with the Science for Afr...

2025-01-15 20:00 5156

Innovation Drives Development and Active Devices Continue to Gain Momentum - 2025 Medtec Further Integrates Resources

SHANGHAI, Jan. 15, 2025 /PRNewswire/ -- Medtec, a comprehensive one-stop platform offering solutions for the design, R&D, and production of medical devices, has garnered widespread recognition and active participation from professionals in the global medical device industry since its inception. T...

2025-01-15 18:07 2790

ASP APAC's VP of Commercial Kevin Neo Spotlights Workplace Culture to Drive Well-balanced Growth

SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Kevin Neo, Vice President of Commercial for APAC (excludingChina and Japan) at Advanced Sterilization Products (ASP), is shaping the future of healthcare, beginning with the communities surrounding ASP. Under Kevin's leadership, the APAC organization of n...

2025-01-15 13:44 3497

Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference

* Celltrion unveils strategic roadmap for the first time outlining its innovative drug development strategy and its plan to submit 13 Investigational New Drug (IND) application by 2028 * Company reinforces its commitment to a two-pillar growth strategy focusing on its groundbreaking new drug ...

2025-01-15 10:52 2736

Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference

- The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April - Samsung Biologics to offer ADC services and invest in advanced development and manufacturing capabilities to better address clients' needs INCHEON, South Korea, Jan. 15, 2025 /PRNewswire/ -- Samsung...

2025-01-15 09:40 2875

Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology

AT03-65 is the first program utilizing AxcynDOT™, a proprietary payload with a differentiated mechanism of action, to enter clinical development SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Axcynsis Therapeutics Pte Ltd ("Axcynsis"), a privately held biopharmaceutical company specialized in deliveri...

2025-01-15 09:00 2484

Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor. SAN FRANCISCO, Jan. 15, 2025 /PRNewswire/ -- Stämm unveiled breakth...

2025-01-15 03:56 2677
1 ... 130131132133134135136 ... 646

Week's Top Stories